Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
It is now one of the most commonly prescribed peptides for weight loss
Ever feel like your internal battery is stuck at 20%
Female participants at the 12mg dose achieved average weight loss of 25.3%, compared to 22.8% for male participants
Clinical trials The US Food and Drug Administration (FDA) has received more than one thousand reports of adverse mental health side effects related to the class of drugs known as GLP-1 agonists to the FDA Adverse Event Reporting System (FAERS)
While semaglutide primarily acts on the GLP-1 receptor, retatrutide's triple-agonist approach provides a more comprehensive mechanism, which may provide faster and greater weight loss
